Table 3 A comparison of the demographic and clinical characteristics of patients with and without secondary infection.

From: Incidence, risk factors and impact on outcomes of secondary infection in patients with septic shock: an 8-year retrospective study

Variables

Non-SI (n = 227)

SI (n = 145)

Univariate analysis

OR(CI95)

P value

Age (years)

 Median (25th, 75th)

61 (51, 71)

66 (58, 78)

 

<0.001

 Age > 65 years, n(%)

83 (36.6%)

78 (53.8%)

2.02 (1.32~3.09)

0.001

 Male, n(%)

124 (54.6%)

93 (64.1%)

1.49 (0.97~2.28)

0.070

Comorbidities

 ≥two comorbidities

42 (18.5%)

36 (24.8%)

1.46 (0.88~2.41)

0.144

Admission category, n(%)

 Medical

194 (85.5%)

111 (75.9%)

  

 Surgical

33 (14.5%)

34 (24.3%)

1.80 (1.06~3.07)

0.029

Immunosupressive agent, n(%)

 Corticosteroid

8 (3.5%)

8 (5.5%)

1.60 (0.57~4.36)

0.355

 Other Immunospressive drugs

11 (4.8%)

6 (4.1%)

0.85 (0.31~2.34)

0.750

 alcohol abuse

64 (28.2%)

41 (28.3%)

1.00 (0.63~1.60)

0.986

Site of infection, n(%)

 Abdominal

88 (38.8%)

56 (38.6%)

0.99 (0.65~1.53)

0.440

 Respiratory tract

59 (26.0%)

43 (29.7%)

1.20 (0.76~1.91)

0.978

 Urinary tract

35 (23.1%)

19 (14.3%)

0.83 (0.45~1.51)

0.536

 Skin and soft tissue

28 (12.3%)

24 (16.8%)

1.41 (0.78~2.54)

0.253

 Positive blood culture, n(%)

81 (35.8%)

51 (35.2%)

0.97 (0.63~1.52)

0.896

SAPS II score at onset of shock

 Median(25th, 75th)

46.0 (39.0, 55.0)

53.00 (45.0, 61.0)

 

<0.001

SOFA score at onset of shock

 Median (25th, 75th)

9.0 (6.0, 11.0)

10.00 (8.00 14.0)

 

<0.001

Duration of shock, Days

 Median (25th, 75th)

4.0 (3.0, 6.0)

(3.0, 10.0)

 

<0.001

Interventions

 Steroid treatment

88 (38.8%)

85 (58.6%)

2.24 (1.46~3.42)

<0.001

 blood transfusion

156 (68.7%)

120 (82.8%)

2.19 (1.31~3.83)

0.003

 Total parenteral nutrition

73 (32.2%)

60 (41.2%)

1.49 (0.97~2.30)

0.070

 Renal replacement therapy

27 (11.9%)

36 (24.8%)

2.45 (1.41~4.24)

0.001

 Intubation

70 (30.8%)

98 (67.6%)

4.68 (2.99~7.32)

<0.001

 Deep vein catheterization

182 (80.2%)

126 (86.9%)

1.64 (0.92~2.94)

0.094

Length of ICU stay

 Median (25th, 75th)

6 (4, 10)

11 (6, 19)

 

<0.001

 ICU mortality, n(%)

58 (25.6%)

62 (42.8%)

 

0.001

Length of hospital stay

 Median (25th, 75th)

13 (8, 20)

19 (11, 33)

 

<0.001

 In-hospital mortality, n(%)

59 (26.0%)

69 (47.6%)

 

<0.001

 Death due to withdrawal of care, n(%)

12 (20.7%)

15 (24.1%)

 

0.067

  1. SAPS II: Simplified Acute Physiology Socre II; SOFA: Sequential Organ Failure Assessment; CI95: 95% confidence intervals; OR: odds ratio.